Background/Aims: Measure Yourself Medical Outcome Profile 2 (MYMOP2) is a patient-generated outcome measure allowing patients to select the problems that are the most important to them and that they want to address, and it measures the effects of the problem from a wide range of health care interventions. This study aimed to translate the questionnaire into Turkish language (Turkish MYMOP-TMYMOP) and add this clinically useful measure to Turkish medical practice by assessing its validity and reliability. Materials and Methods: Fifty volunteers with anorectal disorders were prospectively included into the study. Each patient was enrolled into a pelvic floor training biofeedback program, specific to their anorectal symptomatology. The subjects were administered both the Nottingham Health Profile and the TMYMOP2 questionnaires before the treatment session (initial visit) and at the control follow-up visits (the first and second months, via e-mail or telephone calls). Results: The TMYMOP2 questionnaire was shown to be moderately valid (the Pearson correlation coefficient score between the total scores of the subgroups of the two questionnaires were 0.335 and 0.642, respectively, p<0.05) and highly reliable (the Cronbach’s alfa coefficient score between the total scores of the subgroups of the two questionnaires were 0.77, 0.82, and 0.88 in the beginning and at the first and second month follow-up visits, respectively). Conclusion: The TMYMOP2 was shown to be a low-to-moderately valid and a highly reliable scale. Because it is brief and short to complete, it might be an important and free-to-use tool to measure the diseases, and it can enhance the patient-centered care within the Turkish health care context. Cite this article as: Ersoy Ö, Temel YE, Alptekin HK. Validity and reliability of the measure yourself medical outcome profile 2 (MYMOP2) questionnaire among Turkish patients having anorectal disorders. Turk J Gastroenterol 2019; 30: 28-32.
19 February 2026 in Turkish Journal of Gastroenterology
Background/Aims: The St. Mark’s Incontinence Score (SMIS) is a widely used tool for assessing anal incontinence severity. This studyaimed to evaluate the validity and reliability of the Turkish version of SMIS.Materials and Methods: A cross-sectional validation study with a prospective test–retest component was conducted among 60 patientswith anal incontinence at 2 tertiary hospitals in Istanbul, Türkiye. The original SMIS was translated into Turkish and back-translatedaccording to international translation guidelines. Content and construct validity were assessed by experts’ review and factor analysis.Reliability was evaluated using internal consistency (Cronbach’s alpha) and test–retest reliability.Results: As a result of the evaluations made in line with the opinions of the experts in the “continence field,” it has been shown thatTurkish SMIS (T-SMIS) serves to measure anal incontinence with its content questions and is stated as valid. Reliability analyses indicated adequate internal consistency (Cronbach’s α = 0.76) and high test–retest reliability (intraclass correlation coefficient; r= 0.72-0.87, P = .01-.65).Conclusion: The T-SMIS is a psychometrically sound instrument for assessing fecal incontinence severity. Its adaptation into Turkishfacilitates standardized clinical evaluation and international comparability. Notably, during the work, an Italian validation was published, highlighting the global applicability of SMIS across different cultures (Clinical trial registration: NCT05755763).Cite this article as: Ersoy Ö, Temel YE. Validity and reliability of the Turkish St. Mark’s Incontinence Score. Turk J Gastroenterol.Published online February 19, 2026. doi: 10.5152/tjg.2026.25551.
Background/Objectives: Pelvic floor physiotherapy (PFPT) and biofeedback are established conservative treatments for pelvic floor dysfunctions, but clinical response is heterogeneous. We explored whether exposure to a structured multicomponent set of non-device home practices, described here as adjunctive autonomic regulation practices, was associated with patient-reported improvement when used alongside standard PFPT/biofeedback. The study was exploratory and was not designed to establish an autonomic mechanism or causal treatment effect. Methods: This retrospective, observational, nonconcurrent comparative cohort study included adults treated in the same tertiary pelvic floor rehabilitation unit during two distinct periods. The adjunct-exposed cohort (Group A; September 2022–March 2023) received PFPT/biofeedback plus a structured multicomponent home program; the historical comparator (Group B; January–June 2019) received PFPT/biofeedback without the adjunct. Both programs included diaphragmatic breathing; in the standard program, no fixed breathing rate or duration was prescribed, whereas the adjunct included slow-paced breathing at approximately 6 breaths/min for 5 min three times daily. The primary outcome was the proportion of patients classified as responders according to improvement in the MYMOP2 Profile Score from baseline to approximately 2 months. The historical dataset operationalized clinically meaningful response as >1.0-point improvement. Between-group analyses were unadjusted. Results: A total of 111 patients were analyzed (Group A, n = 35; Group B, n = 76). MYMOP2 response occurred in 31/35 patients (88.6%) in Group A and 42/76 patients (55.3%) in Group B (Pearson chi-square: chi2(1) = 11.81, p < 0.001). The unadjusted risk ratio (RR) was 1.60 (95% CI 1.27–2.03), and the unadjusted absolute difference was 33.3 percentage points (95% CI 17.9–48.7). Using recently proposed physiotherapy-specific RR reference thresholds at a baseline risk near 0.5, the numerical RR lies in the upper medium range and close to the proposed large-effect threshold; this describes magnitude only and does not imply a causal treatment effect. Conclusions: Patients exposed to the adjunctive multicomponent program had a higher unadjusted MYMOP2 responder rate than patients in a nonconcurrent historical standard-rehabilitation cohort. Because the cohorts were separated in time, baseline characterization was incomplete, follow-up availability may have introduced selection bias, historical patient-level MYMOP2 scores are no longer accessible, and the intervention was multicomponent, the findings should be interpreted as exploratory and hypothesis-generating. Prospective studies with concurrent controls, standardized treatment delivery, objective pelvic floor outcomes, and prospectively measured adherence are required.